Healthcare Realty Trust Incorporated (HR)
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
H&R Real Estate Investment Trust (HR.UN:CA) Q1 2026 Earnings Call Transcript
Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
Healthcare Realty Trust Incorporated (HR) Q1 2026 Earnings Call Transcript
Healthcare Realty: Mispriced High-Yield Bargain
Healthcare Realty Trust offers a compelling income and value proposition, trading at a forward P/FFO of 10.8 and yielding 5.6%. HR's strategic reset and portfolio repositioning have improved fundamentals, with same-store NOI up 5.5% YoY and tenant retention rising to 82%. The streamlined portfolio focuses on high-growth outpatient markets, supported by solid balance sheet metrics and favorable demographic tailwinds.
Cinctive Capital Management LP Acquires 136,734 Shares of Healthcare Realty Trust Incorporated $HR
Cinctive Capital Management LP raised its holdings in Healthcare Realty Trust Incorporated (NYSE: HR) by 258.9% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 189,551 shares of the real estate investment trust's stock after acquiring an additional 136,734 shares during the quarter.
H&R Real Estate Investment Trust (HR.UN:CA) Q4 2025 Earnings Call Transcript
H&R Real Estate Investment Trust (HR.UN:CA) Q4 2025 Earnings Call Transcript
Healthcare Realty Trust Incorporated (HR) Q4 2025 Earnings Call Transcript
Healthcare Realty Trust Incorporated (HR) Q4 2025 Earnings Call Transcript
Healthcare Realty Trust (HR) Q4 FFO Meet Estimates
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.4 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.4 per share a year ago.
Healthcare Realty: Buy This Durable REIT While It's Undervalued
Healthcare Realty Trust remains a compelling value and income play, trading at a forward P/FFO of 10.6 and yielding 5.7%. HR demonstrates robust fundamentals with 5% YoY FFO/share growth, 5.4% same-store NOI growth, and near-record tenant retention at 89%. Favorable demographics and secular demand for outpatient medical space underpin HR's growth, with occupancy and leasing pipelines showing continued strength.
What Makes Healthcare Realty Trust (HR) a New Buy Stock
Healthcare Realty Trust (HR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Healthcare Realty Trust Incorporated (HR) Q3 2025 Earnings Call Transcript
Healthcare Realty Trust Incorporated ( HR ) Q3 2025 Earnings Call October 31, 2025 9:00 AM EDT Company Participants Ronald M. Hubbard Peter Scott - President, CEO & Director Robert Hull - Executive VP & COO Austen Helfrich - Executive VP & CFO Ryan Crowley - Executive VP & Chief Investment Officer Conference Call Participants Nicholas Yulico - Scotiabank Global Banking and Markets, Research Division Richard Anderson - Cantor Fitzgerald & Co., Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division Robin Haneland - BMO Capital Markets Equity Research Seth Bergey - Citigroup Inc., Research Division Michael Carroll - RBC Capital Markets, Research Division Michael Gorman - BTIG, LLC, Research Division Michael Mueller - JPMorgan Chase & Co, Research Division John Pawlowski - Green Street Advisors, LLC, Research Division Presentation Operator Good morning, and welcome to Healthcare Realty's Third Quarter 2025 Earnings Conference Call.
Compared to Estimates, Healthcare Realty Trust (HR) Q3 Earnings: A Look at Key Metrics
The headline numbers for Healthcare Realty Trust (HR) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Healthcare Realty Trust (HR) Tops Q3 FFO and Revenue Estimates
Healthcare Realty Trust (HR) came out with quarterly funds from operations (FFO) of $0.41 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to FFO of $0.39 per share a year ago.
